Goodwin Biotechnology is becoming GBI and expanding to launch a brand-new, larger-capacity cGMP biologics facility. Read on to learn how GBI is continuing their mission to provide high-quality, cGMP-compliant manufacturing solutions for companies developing complex biotherapeutics.